

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cellular response to interferon-alpha (GO:0035457) | 6.23671830 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 6.17482499 |
| 3 | negative regulation of cell killing (GO:0031342) | 5.90084169 |
| 4 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.90084169 |
| 5 | type I interferon signaling pathway (GO:0060337) | 5.74497074 |
| 6 | cellular response to type I interferon (GO:0071357) | 5.74497074 |
| 7 | response to type I interferon (GO:0034340) | 5.73343321 |
| 8 | response to interferon-alpha (GO:0035455) | 5.44191925 |
| 9 | neutrophil activation involved in immune response (GO:0002283) | 5.22538049 |
| 10 | positive regulation of interferon-alpha production (GO:0032727) | 5.06392714 |
| 11 | cellular response to interferon-beta (GO:0035458) | 5.05360120 |
| 12 | negative regulation of viral genome replication (GO:0045071) | 4.81526680 |
| 13 | modulation by symbiont of host defense response (GO:0052031) | 4.80323273 |
| 14 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.80323273 |
| 15 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.80323273 |
| 16 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.80323273 |
| 17 | modulation by symbiont of host immune response (GO:0052553) | 4.80323273 |
| 18 | positive regulation by symbiont of host defense response (GO:0052509) | 4.80323273 |
| 19 | regulation of interferon-alpha production (GO:0032647) | 4.70818133 |
| 20 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.61888729 |
| 21 | hydrogen peroxide biosynthetic process (GO:0050665) | 4.59772173 |
| 22 | cellular response to exogenous dsRNA (GO:0071360) | 4.59321522 |
| 23 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.54638389 |
| 24 | regulation of gamma-delta T cell activation (GO:0046643) | 4.54255065 |
| 25 | detection of other organism (GO:0098543) | 4.26784581 |
| 26 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.25396828 |
| 27 | angiotensin maturation (GO:0002003) | 4.23794463 |
| 28 | negative regulation of interleukin-12 production (GO:0032695) | 4.21020653 |
| 29 | granulocyte activation (GO:0036230) | 4.20260469 |
| 30 | production of molecular mediator involved in inflammatory response (GO:0002532) | 4.20002634 |
| 31 | positive regulation of monocyte chemotaxis (GO:0090026) | 4.17552414 |
| 32 | positive regulation of natural killer cell differentiation (GO:0032825) | 4.13911187 |
| 33 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.12659099 |
| 34 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.11656508 |
| 35 | response to interferon-beta (GO:0035456) | 4.08396447 |
| 36 | detection of bacterium (GO:0016045) | 4.05657155 |
| 37 | regulation of RIG-I signaling pathway (GO:0039535) | 4.05064972 |
| 38 | reactive oxygen species biosynthetic process (GO:1903409) | 4.02427225 |
| 39 | macrophage activation involved in immune response (GO:0002281) | 3.97545997 |
| 40 | negative thymic T cell selection (GO:0045060) | 3.96521535 |
| 41 | negative regulation of T cell mediated immunity (GO:0002710) | 3.94602144 |
| 42 | positive thymic T cell selection (GO:0045059) | 3.93541963 |
| 43 | negative T cell selection (GO:0043383) | 3.92708216 |
| 44 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 3.91471245 |
| 45 | respiratory burst (GO:0045730) | 3.89587004 |
| 46 | regulation of T-helper 1 cell differentiation (GO:0045625) | 3.86457151 |
| 47 | positive regulation of type 2 immune response (GO:0002830) | 3.78630435 |
| 48 | response to peptidoglycan (GO:0032494) | 3.78589201 |
| 49 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.77262275 |
| 50 | natural killer cell mediated immunity (GO:0002228) | 3.76351785 |
| 51 | natural killer cell mediated cytotoxicity (GO:0042267) | 3.76351785 |
| 52 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.74909109 |
| 53 | intestinal absorption (GO:0050892) | 3.71756504 |
| 54 | detection of external biotic stimulus (GO:0098581) | 3.69308023 |
| 55 | positive T cell selection (GO:0043368) | 3.68264889 |
| 56 | regulation of interferon-gamma biosynthetic process (GO:0045072) | 3.65959815 |
| 57 | detection of molecule of bacterial origin (GO:0032490) | 3.65619860 |
| 58 | cellular extravasation (GO:0045123) | 3.61748222 |
| 59 | neutrophil activation (GO:0042119) | 3.61676149 |
| 60 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.57987374 |
| 61 | regulation of T cell tolerance induction (GO:0002664) | 3.56380066 |
| 62 | eosinophil chemotaxis (GO:0048245) | 3.55509254 |
| 63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.55231865 |
| 64 | leukocyte aggregation (GO:0070486) | 3.54726338 |
| 65 | regulation of tolerance induction (GO:0002643) | 3.45226519 |
| 66 | positive regulation of interferon-beta production (GO:0032728) | 3.45204904 |
| 67 | T cell selection (GO:0045058) | 3.43969000 |
| 68 | regulation of cholesterol esterification (GO:0010872) | 3.42598831 |
| 69 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.40809303 |
| 70 | response to interleukin-15 (GO:0070672) | 3.40537066 |
| 71 | myeloid cell activation involved in immune response (GO:0002275) | 3.39387847 |
| 72 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 3.35930446 |
| 73 | regulation of monocyte chemotaxis (GO:0090025) | 3.35183855 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.33094513 |
| 75 | intestinal cholesterol absorption (GO:0030299) | 3.31974866 |
| 76 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.30664350 |
| 77 | phospholipid efflux (GO:0033700) | 3.29241215 |
| 78 | regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039531) | 3.28042076 |
| 79 | B cell receptor signaling pathway (GO:0050853) | 3.22872037 |
| 80 | cellular response to virus (GO:0098586) | 3.22628863 |
| 81 | detection of biotic stimulus (GO:0009595) | 3.22309815 |
| 82 | T cell migration (GO:0072678) | 3.21715006 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.21043583 |
| 84 | response to host immune response (GO:0052572) | 3.21043583 |
| 85 | B cell mediated immunity (GO:0019724) | 3.19952402 |
| 86 | positive regulation of T cell cytokine production (GO:0002726) | 3.19932650 |
| 87 | thymic T cell selection (GO:0045061) | 3.17732242 |
| 88 | tolerance induction (GO:0002507) | 3.17569133 |
| 89 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.15202603 |
| 90 | striated muscle atrophy (GO:0014891) | 3.14810682 |
| 91 | positive regulation of interleukin-12 production (GO:0032735) | 3.14151497 |
| 92 | activated T cell proliferation (GO:0050798) | 3.13748581 |
| 93 | cellular response to zinc ion (GO:0071294) | 3.12479341 |
| 94 | response to muramyl dipeptide (GO:0032495) | 3.11965358 |
| 95 | eosinophil migration (GO:0072677) | 3.10618812 |
| 96 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.10413427 |
| 97 | superoxide anion generation (GO:0042554) | 3.07450494 |
| 98 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 3.06996740 |
| 99 | positive regulation of tolerance induction (GO:0002645) | 3.06656143 |
| 100 | defense response to protozoan (GO:0042832) | 3.06588607 |
| 101 | defense response to virus (GO:0051607) | 3.06297607 |
| 102 | positive regulation of response to biotic stimulus (GO:0002833) | 3.06062208 |
| 103 | natural killer cell differentiation (GO:0001779) | 3.03374033 |
| 104 | T-helper 1 type immune response (GO:0042088) | 3.02813865 |
| 105 | regulation of B cell differentiation (GO:0045577) | 3.02571316 |
| 106 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.00083595 |
| 107 | neutrophil mediated immunity (GO:0002446) | 2.99363121 |
| 108 | positive regulation of B cell differentiation (GO:0045579) | 2.98852344 |
| 109 | regulation of regulatory T cell differentiation (GO:0045589) | 2.97408716 |
| 110 | negative regulation of viral process (GO:0048525) | 2.96832497 |
| 111 | cellular response to interleukin-15 (GO:0071350) | 2.95095398 |
| 112 | cellular response to interferon-gamma (GO:0071346) | 2.90874028 |
| 113 | positive regulation of lymphocyte migration (GO:2000403) | 2.89850411 |
| 114 | interferon-gamma secretion (GO:0072643) | 2.88724916 |
| 115 | regulation of necroptotic process (GO:0060544) | 2.87068870 |
| 116 | germinal center formation (GO:0002467) | 2.86124337 |
| 117 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.85478174 |
| 118 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.84408018 |
| 119 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.83270885 |
| 120 | leukocyte mediated cytotoxicity (GO:0001909) | 2.82777904 |
| 121 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.82718916 |
| 122 | interferon-gamma production (GO:0032609) | 2.82219821 |
| 123 | regulation of chemokine biosynthetic process (GO:0045073) | 2.81594393 |
| 124 | hydrogen peroxide metabolic process (GO:0042743) | 2.81557376 |
| 125 | regulation of mononuclear cell migration (GO:0071675) | 2.81049554 |
| 126 | lymphocyte chemotaxis (GO:0048247) | 2.80460989 |
| 127 | regulation of viral genome replication (GO:0045069) | 2.80277051 |
| 128 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.80217701 |
| 129 | regulation of lymphocyte chemotaxis (GO:1901623) | 2.79794368 |
| 130 | regulation of mast cell degranulation (GO:0043304) | 2.79652316 |
| 131 | NIK/NF-kappaB signaling (GO:0038061) | 2.79464093 |
| 132 | positive regulation of granulocyte differentiation (GO:0030854) | 2.79384221 |
| 133 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.79043926 |
| 134 | dendritic cell migration (GO:0036336) | 2.78248214 |
| 135 | dendritic cell chemotaxis (GO:0002407) | 2.78085404 |
| 136 | positive regulation of mast cell activation (GO:0033005) | 2.78045847 |
| 137 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.77255043 |
| 138 | response to host (GO:0075136) | 2.77255043 |
| 139 | response to host defenses (GO:0052200) | 2.77255043 |
| 140 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.75650289 |
| 141 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.75650289 |
| 142 | leukocyte degranulation (GO:0043299) | 2.75182272 |
| 143 | immunoglobulin mediated immune response (GO:0016064) | 2.73891868 |
| 144 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.73731118 |
| 145 | response to protozoan (GO:0001562) | 2.73698811 |
| 146 | negative regulation of erythrocyte differentiation (GO:0045647) | 2.73498630 |
| 147 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.73280940 |
| 148 | histone H3-K36 demethylation (GO:0070544) | 2.73037560 |
| 149 | myeloid leukocyte mediated immunity (GO:0002444) | 2.72522173 |
| 150 | regulation of T cell cytokine production (GO:0002724) | 2.72403681 |
| 151 | negative regulation of innate immune response (GO:0045824) | 2.72079469 |
| 152 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.71167629 |
| 153 | skeletal muscle adaptation (GO:0043501) | 2.67943438 |
| 154 | muscle atrophy (GO:0014889) | 2.66892768 |
| 155 | low-density lipoprotein particle remodeling (GO:0034374) | 2.66084255 |
| 156 | adhesion of symbiont to host cell (GO:0044650) | 2.64588582 |
| 157 | virion attachment to host cell (GO:0019062) | 2.64588582 |
| 158 | microglial cell activation (GO:0001774) | 2.63554167 |
| 159 | response to interferon-gamma (GO:0034341) | 2.62966103 |
| 160 | macrophage activation (GO:0042116) | 2.62098505 |
| 161 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.60945028 |
| 162 | regulation of natural killer cell differentiation (GO:0032823) | 2.60169221 |
| 163 | regulation of T cell chemotaxis (GO:0010819) | 2.60059929 |
| 164 | positive regulation of T cell chemotaxis (GO:0010820) | 2.60059929 |
| 165 | cellular response to vitamin D (GO:0071305) | 2.57407614 |
| 166 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.55475451 |
| 167 | amyloid precursor protein catabolic process (GO:0042987) | 2.52509326 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 8.36005707 |
| 2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.85188342 |
| 3 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 5.78298881 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.15541639 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 4.10513759 |
| 6 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 3.47875020 |
| 7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.41404442 |
| 8 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 3.00554033 |
| 9 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.95883729 |
| 10 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.95643640 |
| 11 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.66760818 |
| 12 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.62938575 |
| 13 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.50307111 |
| 14 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.49985478 |
| 15 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.36511877 |
| 16 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 2.32922043 |
| 17 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.22359857 |
| 18 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19772373 |
| 19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.07782683 |
| 20 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.04951067 |
| 21 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.98087042 |
| 22 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.97593571 |
| 23 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.91660358 |
| 24 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.87905399 |
| 25 | GATA1_22025678_ChIP-Seq_K562_Human | 1.86255970 |
| 26 | UTX_26944678_Chip-Seq_JUKART_Human | 1.85745905 |
| 27 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.82129557 |
| 28 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.78669776 |
| 29 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.71071281 |
| 30 | MYC_22102868_ChIP-Seq_BL_Human | 1.69356513 |
| 31 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.67692814 |
| 32 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.66163536 |
| 33 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.54065847 |
| 34 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.53776333 |
| 35 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.49479565 |
| 36 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.46261188 |
| 37 | MAF_26560356_Chip-Seq_TH2_Human | 1.46027219 |
| 38 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.45109647 |
| 39 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.43494371 |
| 40 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.41580259 |
| 41 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.39911256 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.38215375 |
| 43 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.37203965 |
| 44 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.36211066 |
| 45 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.36174964 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.33917954 |
| 47 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.32699476 |
| 48 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.32350074 |
| 49 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.31676028 |
| 50 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.29916420 |
| 51 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.25939502 |
| 52 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.22011603 |
| 53 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.20679469 |
| 54 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20070497 |
| 55 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.15350843 |
| 56 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.14008591 |
| 57 | SPI1_23127762_ChIP-Seq_K562_Human | 1.13825186 |
| 58 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.13524053 |
| 59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.13236712 |
| 60 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.13180402 |
| 61 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.11818628 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.08882314 |
| 63 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.08876886 |
| 64 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.08821440 |
| 65 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.07999291 |
| 66 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.06293423 |
| 67 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.05689407 |
| 68 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.05121284 |
| 69 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.03915451 |
| 70 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.03309465 |
| 71 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03046854 |
| 72 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.02692699 |
| 73 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.02556226 |
| 74 | MYB_26560356_Chip-Seq_TH2_Human | 1.01261438 |
| 75 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.01204214 |
| 76 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.99782845 |
| 77 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.99564914 |
| 78 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99132613 |
| 79 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98368969 |
| 80 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97871762 |
| 81 | SPI1_23547873_ChIP-Seq_NB4_Human | 0.97855408 |
| 82 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 0.97721651 |
| 83 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96916822 |
| 84 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.96053811 |
| 85 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.95809864 |
| 86 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.94426698 |
| 87 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94265429 |
| 88 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 0.93531410 |
| 89 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.92635731 |
| 90 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.92479191 |
| 91 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.92479191 |
| 92 | MYB_26560356_Chip-Seq_TH1_Human | 0.92429498 |
| 93 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.92336489 |
| 94 | GATA6_25053715_ChIP-Seq_YYC3_Human | 0.91840340 |
| 95 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.91493035 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 0.89691521 |
| 97 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 0.89436486 |
| 98 | GATA3_26560356_Chip-Seq_TH2_Human | 0.89409134 |
| 99 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.88851116 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.88413941 |
| 101 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.86931817 |
| 102 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86818469 |
| 103 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.86381449 |
| 104 | MAF_26560356_Chip-Seq_TH1_Human | 0.86287455 |
| 105 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.84198977 |
| 106 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 0.83138535 |
| 107 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.82806918 |
| 108 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81551482 |
| 109 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.81174417 |
| 110 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.81090818 |
| 111 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.80327984 |
| 112 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.79477088 |
| 113 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.78973055 |
| 114 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.78238063 |
| 115 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.77002642 |
| 116 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.76634637 |
| 117 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.76084181 |
| 118 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.76037542 |
| 119 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.75589255 |
| 120 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.75179797 |
| 121 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.74036182 |
| 122 | CJUN_26792858_Chip-Seq_BT549_Human | 0.73173481 |
| 123 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.73168254 |
| 124 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71794369 |
| 125 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.71702118 |
| 126 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71108587 |
| 127 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.70806134 |
| 128 | GATA1_19941826_ChIP-Seq_K562_Human | 0.70686310 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.69786131 |
| 130 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.68496246 |
| 131 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.66389610 |
| 132 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.66171953 |
| 133 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.65759681 |
| 134 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.65038684 |
| 135 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.64849126 |
| 136 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.64380748 |
| 137 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.64279967 |
| 138 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.64065030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 4.58971327 |
| 2 | MP0002148_abnormal_hypersensitivity_rea | 3.70930756 |
| 3 | MP0009785_altered_susceptibility_to | 3.53478500 |
| 4 | MP0003724_increased_susceptibility_to | 3.30002748 |
| 5 | MP0003436_decreased_susceptibility_to | 3.29083295 |
| 6 | MP0001835_abnormal_antigen_presentation | 3.28113433 |
| 7 | MP0009840_abnormal_foam_cell | 2.97702880 |
| 8 | MP0006082_CNS_inflammation | 2.94172392 |
| 9 | MP0005025_abnormal_response_to | 2.75747270 |
| 10 | MP0003763_abnormal_thymus_physiology | 2.74399025 |
| 11 | MP0004510_myositis | 2.68905499 |
| 12 | MP0005000_abnormal_immune_tolerance | 2.68716571 |
| 13 | MP0003191_abnormal_cellular_cholesterol | 2.67001844 |
| 14 | MP0003303_peritoneal_inflammation | 2.66678351 |
| 15 | MP0002419_abnormal_innate_immunity | 2.48511974 |
| 16 | MP0005387_immune_system_phenotype | 2.40458070 |
| 17 | MP0001790_abnormal_immune_system | 2.40458070 |
| 18 | MP0000685_abnormal_immune_system | 2.37285944 |
| 19 | MP0005671_abnormal_response_to | 2.25959479 |
| 20 | MP0008260_abnormal_autophagy | 2.18906584 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.13076514 |
| 22 | MP0001853_heart_inflammation | 2.12184344 |
| 23 | MP0001533_abnormal_skeleton_physiology | 2.05420035 |
| 24 | MP0002452_abnormal_antigen_presenting | 2.04468231 |
| 25 | MP0002723_abnormal_immune_serum | 1.96517210 |
| 26 | MP0001666_abnormal_nutrient_absorption | 1.96292758 |
| 27 | MP0009764_decreased_sensitivity_to | 1.95681923 |
| 28 | MP0004947_skin_inflammation | 1.94071997 |
| 29 | MP0005058_abnormal_lysosome_morphology | 1.93048811 |
| 30 | MP0005464_abnormal_platelet_physiology | 1.85852734 |
| 31 | MP0001800_abnormal_humoral_immune | 1.83180509 |
| 32 | MP0010155_abnormal_intestine_physiology | 1.76784678 |
| 33 | MP0005310_abnormal_salivary_gland | 1.76115656 |
| 34 | MP0004043_abnormal_pH_regulation | 1.71963190 |
| 35 | MP0001819_abnormal_immune_cell | 1.71114108 |
| 36 | MP0002254_reproductive_system_inflammat | 1.69183724 |
| 37 | MP0002139_abnormal_hepatobiliary_system | 1.68512786 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.66786303 |
| 39 | MP0008469_abnormal_protein_level | 1.66499711 |
| 40 | MP0004782_abnormal_surfactant_physiolog | 1.61412673 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.61396273 |
| 42 | MP0002396_abnormal_hematopoietic_system | 1.58331407 |
| 43 | MP0003866_abnormal_defecation | 1.54660617 |
| 44 | MP0000689_abnormal_spleen_morphology | 1.53257437 |
| 45 | MP0003075_altered_response_to | 1.52982954 |
| 46 | MP0002722_abnormal_immune_system | 1.49437856 |
| 47 | MP0003828_pulmonary_edema | 1.44502053 |
| 48 | MP0005167_abnormal_blood-brain_barrier | 1.42707093 |
| 49 | MP0000465_gastrointestinal_hemorrhage | 1.41201809 |
| 50 | MP0003195_calcinosis | 1.41135947 |
| 51 | MP0000703_abnormal_thymus_morphology | 1.39625831 |
| 52 | MP0004019_abnormal_vitamin_homeostasis | 1.36291530 |
| 53 | MP0003448_altered_tumor_morphology | 1.32845300 |
| 54 | MP0004883_abnormal_blood_vessel | 1.29195223 |
| 55 | MP0002277_abnormal_respiratory_mucosa | 1.28464019 |
| 56 | MP0004381_abnormal_hair_follicle | 1.26114777 |
| 57 | MP0002405_respiratory_system_inflammati | 1.25250024 |
| 58 | MP0002006_tumorigenesis | 1.25086649 |
| 59 | MP0009643_abnormal_urine_homeostasis | 1.25068456 |
| 60 | MP0003705_abnormal_hypodermis_morpholog | 1.25000263 |
| 61 | MP0000604_amyloidosis | 1.21619862 |
| 62 | MP0003186_abnormal_redox_activity | 1.21423011 |
| 63 | MP0001851_eye_inflammation | 1.19738580 |
| 64 | MP0005166_decreased_susceptibility_to | 1.18701543 |
| 65 | MP0003172_abnormal_lysosome_physiology | 1.17479440 |
| 66 | MP0002136_abnormal_kidney_physiology | 1.16465439 |
| 67 | MP0002132_abnormal_respiratory_system | 1.15384283 |
| 68 | MP0001663_abnormal_digestive_system | 1.15326805 |
| 69 | MP0003252_abnormal_bile_duct | 1.14371211 |
| 70 | MP0005332_abnormal_amino_acid | 1.11166900 |
| 71 | MP0005085_abnormal_gallbladder_physiolo | 1.09596187 |
| 72 | MP0002998_abnormal_bone_remodeling | 1.07658052 |
| 73 | MP0002009_preneoplasia | 1.07572747 |
| 74 | MP0010329_abnormal_lipoprotein_level | 1.07165212 |
| 75 | MP0006054_spinal_hemorrhage | 1.06576610 |
| 76 | MP0000716_abnormal_immune_system | 1.06566634 |
| 77 | MP0003656_abnormal_erythrocyte_physiolo | 1.04827330 |
| 78 | MP0000858_altered_metastatic_potential | 1.03516052 |
| 79 | MP0003300_gastrointestinal_ulcer | 1.03471145 |
| 80 | MP0000569_abnormal_digit_pigmentation | 1.02403264 |
| 81 | MP0005164_abnormal_response_to | 1.02277334 |
| 82 | MP0009333_abnormal_splenocyte_physiolog | 1.00918266 |
| 83 | MP0010386_abnormal_urinary_bladder | 0.97709181 |
| 84 | MP0001765_abnormal_ion_homeostasis | 0.97468170 |
| 85 | MP0000490_abnormal_crypts_of | 0.97339006 |
| 86 | MP0004264_abnormal_extraembryonic_tissu | 0.97002431 |
| 87 | MP0008004_abnormal_stomach_pH | 0.96250691 |
| 88 | MP0000538_abnormal_urinary_bladder | 0.93613223 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.92428351 |
| 90 | MP0001756_abnormal_urination | 0.92284143 |
| 91 | MP0010234_abnormal_vibrissa_follicle | 0.90080006 |
| 92 | MP0005636_abnormal_mineral_homeostasis | 0.89960917 |
| 93 | MP0005381_digestive/alimentary_phenotyp | 0.89622274 |
| 94 | MP0003690_abnormal_glial_cell | 0.88520710 |
| 95 | MP0000015_abnormal_ear_pigmentation | 0.88446239 |
| 96 | MP0005365_abnormal_bile_salt | 0.87690214 |
| 97 | MP0004858_abnormal_nervous_system | 0.86131915 |
| 98 | MP0002398_abnormal_bone_marrow | 0.85008997 |
| 99 | MP0005451_abnormal_body_composition | 0.82991459 |
| 100 | MP0003045_fibrosis | 0.82607126 |
| 101 | MP0003646_muscle_fatigue | 0.81039916 |
| 102 | MP0002138_abnormal_hepatobiliary_system | 0.80916930 |
| 103 | MP0002933_joint_inflammation | 0.79714357 |
| 104 | MP0000343_altered_response_to | 0.79487177 |
| 105 | MP0000249_abnormal_blood_vessel | 0.78964085 |
| 106 | MP0002429_abnormal_blood_cell | 0.78205752 |
| 107 | MP0009278_abnormal_bone_marrow | 0.78024631 |
| 108 | MP0003091_abnormal_cell_migration | 0.78021997 |
| 109 | MP0009763_increased_sensitivity_to | 0.77436227 |
| 110 | MP0005390_skeleton_phenotype | 0.77150539 |
| 111 | MP0003566_abnormal_cell_adhesion | 0.77147134 |
| 112 | MP0005075_abnormal_melanosome_morpholog | 0.75827119 |
| 113 | MP0004808_abnormal_hematopoietic_stem | 0.75537881 |
| 114 | MP0005448_abnormal_energy_balance | 0.74305183 |
| 115 | MP0005535_abnormal_body_temperature | 0.74031740 |
| 116 | MP0004147_increased_porphyrin_level | 0.72497222 |
| 117 | MP0003806_abnormal_nucleotide_metabolis | 0.71447847 |
| 118 | MP0009765_abnormal_xenobiotic_induced | 0.70085774 |
| 119 | MP0002693_abnormal_pancreas_physiology | 0.68724241 |
| 120 | MP0005076_abnormal_cell_differentiation | 0.68301015 |
| 121 | MP0009115_abnormal_fat_cell | 0.67988173 |
| 122 | MP0003453_abnormal_keratinocyte_physiol | 0.67908588 |
| 123 | MP0000609_abnormal_liver_physiology | 0.67268187 |
| 124 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.66889826 |
| 125 | MP0002332_abnormal_exercise_endurance | 0.66610226 |
| 126 | MP0002166_altered_tumor_susceptibility | 0.66263955 |
| 127 | MP0005409_darkened_coat_color | 0.65268654 |
| 128 | MP0001545_abnormal_hematopoietic_system | 0.64360117 |
| 129 | MP0005397_hematopoietic_system_phenotyp | 0.64360117 |
| 130 | MP0001873_stomach_inflammation | 0.63788806 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Autoimmune thrombocytopenia (HP:0001973) | 7.78540533 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.24019222 |
| 3 | Recurrent bacterial skin infections (HP:0005406) | 5.41041965 |
| 4 | Recurrent gram-negative bacterial infections (HP:0005420) | 5.33789471 |
| 5 | Recurrent abscess formation (HP:0002722) | 5.17591855 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 4.96903267 |
| 7 | Systemic lupus erythematosus (HP:0002725) | 4.73156705 |
| 8 | Abnormality of macrophages (HP:0004311) | 4.60871556 |
| 9 | T lymphocytopenia (HP:0005403) | 4.33854460 |
| 10 | Increased IgM level (HP:0003496) | 4.32042198 |
| 11 | Abnormality of T cell number (HP:0011839) | 4.13045233 |
| 12 | Gastrointestinal infarctions (HP:0005244) | 4.08070494 |
| 13 | Mediastinal lymphadenopathy (HP:0100721) | 4.01246202 |
| 14 | Gingivitis (HP:0000230) | 3.88858988 |
| 15 | Pigmentary retinal degeneration (HP:0001146) | 3.75077290 |
| 16 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.72612767 |
| 17 | Basal ganglia calcification (HP:0002135) | 3.72383731 |
| 18 | Axonal loss (HP:0003447) | 3.71288831 |
| 19 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.60651506 |
| 20 | Vacuolated lymphocytes (HP:0001922) | 3.60035298 |
| 21 | Poor head control (HP:0002421) | 3.54132528 |
| 22 | Autoimmune hemolytic anemia (HP:0001890) | 3.51169583 |
| 23 | Meningitis (HP:0001287) | 3.50365854 |
| 24 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.38948348 |
| 25 | Recurrent cutaneous fungal infections (HP:0011370) | 3.38948348 |
| 26 | Micronodular cirrhosis (HP:0001413) | 3.33777059 |
| 27 | Encephalitis (HP:0002383) | 3.31655702 |
| 28 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.30460627 |
| 29 | Spontaneous hematomas (HP:0007420) | 3.26220105 |
| 30 | Keratoconjunctivitis sicca (HP:0001097) | 3.24161918 |
| 31 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.20145995 |
| 32 | Stomatitis (HP:0010280) | 3.17057931 |
| 33 | Petechiae (HP:0000967) | 3.14108303 |
| 34 | Abnormality of T cells (HP:0002843) | 3.12156327 |
| 35 | Increased cerebral lipofuscin (HP:0011813) | 3.07414759 |
| 36 | Abnormality of proline metabolism (HP:0010907) | 3.06578596 |
| 37 | Hydroxyprolinuria (HP:0003080) | 3.06578596 |
| 38 | Vasculitis (HP:0002633) | 3.05165043 |
| 39 | Chest pain (HP:0100749) | 3.04238434 |
| 40 | Recurrent fungal infections (HP:0002841) | 3.03689411 |
| 41 | Recurrent viral infections (HP:0004429) | 3.03258671 |
| 42 | Hemoptysis (HP:0002105) | 2.99777140 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.99033629 |
| 44 | Interstitial pulmonary disease (HP:0006530) | 2.97149465 |
| 45 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 2.92367461 |
| 46 | Progressive visual loss (HP:0000529) | 2.92217056 |
| 47 | Inflammation of the large intestine (HP:0002037) | 2.89233464 |
| 48 | Recurrent skin infections (HP:0001581) | 2.86333507 |
| 49 | Leukocytosis (HP:0001974) | 2.76648090 |
| 50 | Colitis (HP:0002583) | 2.76559015 |
| 51 | Gastrointestinal inflammation (HP:0004386) | 2.75752325 |
| 52 | Hemorrhage of the eye (HP:0011885) | 2.74538064 |
| 53 | Pustule (HP:0200039) | 2.73554365 |
| 54 | Orchitis (HP:0100796) | 2.72928026 |
| 55 | Hypergammaglobulinemia (HP:0010702) | 2.72306953 |
| 56 | Amyloidosis (HP:0011034) | 2.69102956 |
| 57 | Periodontitis (HP:0000704) | 2.68218173 |
| 58 | Prolonged bleeding time (HP:0003010) | 2.67485090 |
| 59 | Epistaxis (HP:0000421) | 2.63268351 |
| 60 | Slow saccadic eye movements (HP:0000514) | 2.61811847 |
| 61 | Arterial thrombosis (HP:0004420) | 2.60251515 |
| 62 | Thick nail (HP:0001805) | 2.55628495 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.55618985 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.53794975 |
| 65 | Increased IgE level (HP:0003212) | 2.52256414 |
| 66 | Peritonitis (HP:0002586) | 2.51471306 |
| 67 | Pulmonary embolism (HP:0002204) | 2.50903042 |
| 68 | Porencephaly (HP:0002132) | 2.49056413 |
| 69 | Panhypogammaglobulinemia (HP:0003139) | 2.48752630 |
| 70 | Optic neuritis (HP:0100653) | 2.47641144 |
| 71 | Retrobulbar optic neuritis (HP:0100654) | 2.47641144 |
| 72 | Recurrent bronchitis (HP:0002837) | 2.47492261 |
| 73 | Purpura (HP:0000979) | 2.45189129 |
| 74 | Chronic diarrhea (HP:0002028) | 2.44840843 |
| 75 | Tetraparesis (HP:0002273) | 2.44053909 |
| 76 | Nephritis (HP:0000123) | 2.43143576 |
| 77 | Abnormality of chloride homeostasis (HP:0011422) | 2.41960264 |
| 78 | Urticaria (HP:0001025) | 2.41116717 |
| 79 | Anorexia (HP:0002039) | 2.39720264 |
| 80 | Chronic obstructive pulmonary disease (HP:0006510) | 2.39062095 |
| 81 | Obstructive lung disease (HP:0006536) | 2.39062095 |
| 82 | Granulocytopenia (HP:0001913) | 2.38287954 |
| 83 | Myositis (HP:0100614) | 2.35346272 |
| 84 | Combined immunodeficiency (HP:0005387) | 2.34551134 |
| 85 | Abnormality of T cell physiology (HP:0011840) | 2.33877556 |
| 86 | Episodic fever (HP:0001954) | 2.29856137 |
| 87 | Gangrene (HP:0100758) | 2.28953378 |
| 88 | Abnormality of the pleura (HP:0002103) | 2.27986472 |
| 89 | Lymphopenia (HP:0001888) | 2.27904538 |
| 90 | Osteomyelitis (HP:0002754) | 2.27830540 |
| 91 | Lower limb hyperreflexia (HP:0002395) | 2.26188074 |
| 92 | Cellulitis (HP:0100658) | 2.24291273 |
| 93 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.20336177 |
| 94 | Hyperactive renin-angiotensin system (HP:0000841) | 2.19902601 |
| 95 | Prolonged neonatal jaundice (HP:0006579) | 2.19387243 |
| 96 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.17836679 |
| 97 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.17836679 |
| 98 | Abnormality of glycolipid metabolism (HP:0010969) | 2.17836679 |
| 99 | Gingival bleeding (HP:0000225) | 2.17543484 |
| 100 | Metabolic alkalosis (HP:0200114) | 2.17315484 |
| 101 | Joint swelling (HP:0001386) | 2.16963575 |
| 102 | Ileus (HP:0002595) | 2.16879400 |
| 103 | Abnormality of the peritoneum (HP:0002585) | 2.14983299 |
| 104 | Hypochromic anemia (HP:0001931) | 2.13707350 |
| 105 | Dysostosis multiplex (HP:0000943) | 2.13545411 |
| 106 | Abnormality of the pericardium (HP:0001697) | 2.09139971 |
| 107 | Abnormality of the fingertips (HP:0001211) | 2.06880255 |
| 108 | IgM deficiency (HP:0002850) | 2.06435494 |
| 109 | Disinhibition (HP:0000734) | 2.06332637 |
| 110 | Esophageal neoplasm (HP:0100751) | 2.06242329 |
| 111 | Neoplasm of head and neck (HP:0012288) | 2.06242329 |
| 112 | Glomerulopathy (HP:0100820) | 2.05180863 |
| 113 | Subacute progressive viral hepatitis (HP:0006572) | 2.04423837 |
| 114 | Retinal atrophy (HP:0001105) | 2.01410990 |
| 115 | Pathologic fracture (HP:0002756) | 2.00288920 |
| 116 | Eosinophilia (HP:0001880) | 2.00168149 |
| 117 | Chronic otitis media (HP:0000389) | 1.96344899 |
| 118 | Hand muscle atrophy (HP:0009130) | 1.93914909 |
| 119 | Acute hepatic failure (HP:0006554) | 1.93084079 |
| 120 | Skin ulcer (HP:0200042) | 1.92670049 |
| 121 | Viral hepatitis (HP:0006562) | 1.90986592 |
| 122 | Abnormality of eosinophils (HP:0001879) | 1.90259132 |
| 123 | Recurrent pneumonia (HP:0006532) | 1.90140270 |
| 124 | Cleft eyelid (HP:0000625) | 1.89540357 |
| 125 | Mucopolysacchariduria (HP:0008155) | 1.89171871 |
| 126 | Urinary glycosaminoglycan excretion (HP:0003541) | 1.89171871 |
| 127 | Abnormality of the basal ganglia (HP:0002134) | 1.88573988 |
| 128 | Hepatosplenomegaly (HP:0001433) | 1.87897549 |
| 129 | Pulmonary infiltrates (HP:0002113) | 1.87343622 |
| 130 | Joint hemorrhage (HP:0005261) | 1.87228218 |
| 131 | Agammaglobulinemia (HP:0004432) | 1.86175154 |
| 132 | Hypochromic microcytic anemia (HP:0004840) | 1.86163643 |
| 133 | Nasal polyposis (HP:0100582) | 1.85798923 |
| 134 | Hematochezia (HP:0002573) | 1.84968917 |
| 135 | Acanthocytosis (HP:0001927) | 1.84779094 |
| 136 | Polyneuropathy (HP:0001271) | 1.83764525 |
| 137 | Premature loss of primary teeth (HP:0006323) | 1.83752423 |
| 138 | Thrombophlebitis (HP:0004418) | 1.83601782 |
| 139 | Skin rash (HP:0000988) | 1.83397875 |
| 140 | Cheilitis (HP:0100825) | 1.83116584 |
| 141 | Increased serum ferritin (HP:0003281) | 1.82996435 |
| 142 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.82534263 |
| 143 | Glycosuria (HP:0003076) | 1.81939283 |
| 144 | Abnormality of urine glucose concentration (HP:0011016) | 1.81939283 |
| 145 | Cupped ribs (HP:0000887) | 1.78769303 |
| 146 | Abnormality of nucleobase metabolism (HP:0010932) | 1.76169919 |
| 147 | Spastic tetraparesis (HP:0001285) | 1.74899709 |
| 148 | Pancreatitis (HP:0001733) | 1.74394305 |
| 149 | Sepsis (HP:0100806) | 1.73569779 |
| 150 | Malnutrition (HP:0004395) | 1.73092033 |
| 151 | Loss of speech (HP:0002371) | 1.72117122 |
| 152 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.69535458 |
| 153 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.69535458 |
| 154 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.69535458 |
| 155 | Nausea (HP:0002018) | 1.68500418 |
| 156 | Hyperglycinuria (HP:0003108) | 1.67661529 |
| 157 | Progressive microcephaly (HP:0000253) | 1.65496814 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PBK | 4.80364671 |
| 2 | MAP3K14 | 3.79641441 |
| 3 | BLK | 3.61830677 |
| 4 | MST1R | 3.58720560 |
| 5 | SIK3 | 3.56901615 |
| 6 | TYK2 | 3.38108763 |
| 7 | PIM2 | 3.12075369 |
| 8 | RIPK4 | 3.03488986 |
| 9 | TBK1 | 2.65821013 |
| 10 | PRPF4B | 2.39532571 |
| 11 | SIK1 | 2.27356131 |
| 12 | BMX | 2.26093384 |
| 13 | MAP2K3 | 2.22998903 |
| 14 | SIK2 | 1.98335302 |
| 15 | MARK3 | 1.92087619 |
| 16 | IKBKE | 1.90531762 |
| 17 | WNK4 | 1.76709123 |
| 18 | JAK3 | 1.75983842 |
| 19 | JAK1 | 1.68697514 |
| 20 | ARAF | 1.66020452 |
| 21 | MAP3K12 | 1.65791212 |
| 22 | MST4 | 1.60852552 |
| 23 | ERN1 | 1.60704904 |
| 24 | FGR | 1.60133740 |
| 25 | ITK | 1.57682395 |
| 26 | MAP3K3 | 1.54437968 |
| 27 | MATK | 1.54299172 |
| 28 | TAOK1 | 1.49323043 |
| 29 | CSK | 1.48053252 |
| 30 | PRKG2 | 1.46168382 |
| 31 | FGFR4 | 1.43085089 |
| 32 | BMPR2 | 1.41793082 |
| 33 | CSF1R | 1.30026950 |
| 34 | ACVR1B | 1.29711100 |
| 35 | TESK1 | 1.29241643 |
| 36 | MAP3K13 | 1.27443836 |
| 37 | IRAK4 | 1.26687204 |
| 38 | TEC | 1.25518092 |
| 39 | EPHB1 | 1.24806527 |
| 40 | MAP4K1 | 1.24321464 |
| 41 | KIT | 1.23165465 |
| 42 | IKBKB | 1.21123946 |
| 43 | MAP3K2 | 1.20452591 |
| 44 | WNK3 | 1.14634939 |
| 45 | NLK | 1.14551597 |
| 46 | TNK2 | 1.14285843 |
| 47 | WNK1 | 1.12682764 |
| 48 | FRK | 1.12090982 |
| 49 | CDC42BPA | 1.09852314 |
| 50 | TAOK3 | 1.09180790 |
| 51 | RIPK1 | 1.07138540 |
| 52 | SYK | 1.06614964 |
| 53 | YES1 | 1.05950590 |
| 54 | GRK6 | 1.02615426 |
| 55 | MAP3K11 | 1.02354144 |
| 56 | ABL2 | 1.01966647 |
| 57 | PIM1 | 0.99421221 |
| 58 | STK4 | 0.97902300 |
| 59 | IRAK1 | 0.94870832 |
| 60 | NME2 | 0.93354393 |
| 61 | CHUK | 0.92281062 |
| 62 | LMTK2 | 0.92169808 |
| 63 | MARK2 | 0.86915236 |
| 64 | JAK2 | 0.85443288 |
| 65 | TAOK2 | 0.84099490 |
| 66 | PTK6 | 0.82984549 |
| 67 | FER | 0.82695965 |
| 68 | TGFBR2 | 0.82480848 |
| 69 | MAPK11 | 0.81981571 |
| 70 | CDK12 | 0.80945602 |
| 71 | MET | 0.80898589 |
| 72 | MAP3K10 | 0.80791180 |
| 73 | STK39 | 0.80410552 |
| 74 | PRKCD | 0.79220617 |
| 75 | TRPM7 | 0.77068240 |
| 76 | KSR2 | 0.73881616 |
| 77 | HCK | 0.72438967 |
| 78 | PIK3CG | 0.72306364 |
| 79 | ZAP70 | 0.71317471 |
| 80 | IRAK2 | 0.69891373 |
| 81 | MAPK7 | 0.67680850 |
| 82 | LYN | 0.67493119 |
| 83 | GRK7 | 0.65347021 |
| 84 | FGFR3 | 0.64909353 |
| 85 | ERBB3 | 0.64649954 |
| 86 | MAP3K7 | 0.63536358 |
| 87 | OXSR1 | 0.62196569 |
| 88 | FYN | 0.61929931 |
| 89 | IRAK3 | 0.61390815 |
| 90 | ERBB4 | 0.60020827 |
| 91 | EPHB2 | 0.56343934 |
| 92 | CAMKK2 | 0.53851756 |
| 93 | SGK3 | 0.53556060 |
| 94 | TRIB3 | 0.53351171 |
| 95 | CDK6 | 0.52925985 |
| 96 | MAPK12 | 0.52696776 |
| 97 | MAP3K6 | 0.51654114 |
| 98 | CDK4 | 0.50266923 |
| 99 | MAP3K1 | 0.49611542 |
| 100 | PRKCQ | 0.49487351 |
| 101 | DYRK1B | 0.49410227 |
| 102 | PTK2B | 0.48446391 |
| 103 | LCK | 0.48020575 |
| 104 | ABL1 | 0.46581614 |
| 105 | SGK2 | 0.46408082 |
| 106 | PRKCE | 0.45740674 |
| 107 | HIPK2 | 0.45334482 |
| 108 | MELK | 0.44745545 |
| 109 | STK10 | 0.44490229 |
| 110 | MAP2K2 | 0.43452496 |
| 111 | MUSK | 0.42549631 |
| 112 | TXK | 0.42471010 |
| 113 | PDPK1 | 0.41844801 |
| 114 | BRD4 | 0.41053489 |
| 115 | MAP3K5 | 0.40392691 |
| 116 | EGFR | 0.39662129 |
| 117 | EPHA3 | 0.39523837 |
| 118 | STK11 | 0.38766750 |
| 119 | PDGFRB | 0.38266609 |
| 120 | RET | 0.36834556 |
| 121 | TESK2 | 0.35625179 |
| 122 | MAP2K6 | 0.35422493 |
| 123 | PDK1 | 0.35406279 |
| 124 | BTK | 0.35232359 |
| 125 | BCR | 0.34811199 |
| 126 | STK24 | 0.34354937 |
| 127 | PTK2 | 0.32132321 |
| 128 | SRC | 0.30767206 |
| 129 | CAMKK1 | 0.30209828 |
| 130 | DAPK3 | 0.29789681 |
| 131 | MAPKAPK2 | 0.28946724 |
| 132 | LRRK2 | 0.28312087 |
| 133 | PRKACG | 0.27971224 |
| 134 | FES | 0.24634906 |
| 135 | ERBB2 | 0.23584981 |
| 136 | MAP3K9 | 0.23526290 |
| 137 | PRKAA1 | 0.22948602 |
| 138 | INSR | 0.22795902 |
| 139 | RPS6KA1 | 0.22558580 |
| 140 | STK38 | 0.22205461 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 3.50310762 |
| 2 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.65648216 |
| 3 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.53791245 |
| 4 | Mineral absorption_Homo sapiens_hsa04978 | 2.46038757 |
| 5 | Leishmaniasis_Homo sapiens_hsa05140 | 2.44078326 |
| 6 | Fat digestion and absorption_Homo sapiens_hsa04975 | 2.24453904 |
| 7 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.21865439 |
| 8 | Allograft rejection_Homo sapiens_hsa05330 | 2.18802735 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.10552675 |
| 10 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.01070633 |
| 11 | Influenza A_Homo sapiens_hsa05164 | 1.99515407 |
| 12 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.96083913 |
| 13 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.84798657 |
| 14 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.83788790 |
| 15 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.80827327 |
| 16 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.79968412 |
| 17 | Legionellosis_Homo sapiens_hsa05134 | 1.75680406 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.74389123 |
| 19 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.74189291 |
| 20 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.65877609 |
| 21 | Asthma_Homo sapiens_hsa05310 | 1.64954592 |
| 22 | Salmonella infection_Homo sapiens_hsa05132 | 1.64484708 |
| 23 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.60907429 |
| 24 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.56893133 |
| 25 | Malaria_Homo sapiens_hsa05144 | 1.55220083 |
| 26 | Measles_Homo sapiens_hsa05162 | 1.51449365 |
| 27 | African trypanosomiasis_Homo sapiens_hsa05143 | 1.50506453 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45589358 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.41964797 |
| 30 | Tuberculosis_Homo sapiens_hsa05152 | 1.41468085 |
| 31 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.33133475 |
| 32 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.32062425 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.30594298 |
| 34 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.22378698 |
| 35 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.19948573 |
| 36 | Hepatitis C_Homo sapiens_hsa05160 | 1.19821380 |
| 37 | Lysosome_Homo sapiens_hsa04142 | 1.16714273 |
| 38 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.14421840 |
| 39 | Other glycan degradation_Homo sapiens_hsa00511 | 1.14392891 |
| 40 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.13779079 |
| 41 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.10530307 |
| 42 | Galactose metabolism_Homo sapiens_hsa00052 | 1.07928388 |
| 43 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.06381582 |
| 44 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.05219536 |
| 45 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.03744228 |
| 46 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01962500 |
| 47 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.01357972 |
| 48 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.99902565 |
| 49 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.98800817 |
| 50 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.97836600 |
| 51 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.97374741 |
| 52 | Viral myocarditis_Homo sapiens_hsa05416 | 0.94681913 |
| 53 | Phagosome_Homo sapiens_hsa04145 | 0.94227632 |
| 54 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.93643694 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.93562300 |
| 56 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.87846809 |
| 57 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.85612215 |
| 58 | Bile secretion_Homo sapiens_hsa04976 | 0.82167309 |
| 59 | Apoptosis_Homo sapiens_hsa04210 | 0.81783238 |
| 60 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.79646645 |
| 61 | Shigellosis_Homo sapiens_hsa05131 | 0.79100755 |
| 62 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.78249791 |
| 63 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.76010736 |
| 64 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.74811444 |
| 65 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.74175958 |
| 66 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.74060416 |
| 67 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.74031087 |
| 68 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.73749873 |
| 69 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.72222965 |
| 70 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.72129433 |
| 71 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.71701079 |
| 72 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.69097486 |
| 73 | Histidine metabolism_Homo sapiens_hsa00340 | 0.67949433 |
| 74 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.67669922 |
| 75 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.67047394 |
| 76 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.65623537 |
| 77 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.62989889 |
| 78 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.62683289 |
| 79 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.62584896 |
| 80 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.59999971 |
| 81 | Hepatitis B_Homo sapiens_hsa05161 | 0.57386281 |
| 82 | Amoebiasis_Homo sapiens_hsa05146 | 0.57214808 |
| 83 | Prion diseases_Homo sapiens_hsa05020 | 0.55593372 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.54112531 |
| 85 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.53459373 |
| 86 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52536156 |
| 87 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52237522 |
| 88 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.51659281 |
| 89 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.50825967 |
| 90 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.50632860 |
| 91 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50142258 |
| 92 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.49302251 |
| 93 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.47023630 |
| 94 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.46854017 |
| 95 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.46300801 |
| 96 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.46134436 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.45844901 |
| 98 | Platelet activation_Homo sapiens_hsa04611 | 0.44961734 |
| 99 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.44090785 |
| 100 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.44088148 |
| 101 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.43694127 |
| 102 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.42961566 |
| 103 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.42388973 |
| 104 | Endocytosis_Homo sapiens_hsa04144 | 0.39998685 |
| 105 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.39867624 |
| 106 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.39756527 |
| 107 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.39662474 |
| 108 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.39013992 |
| 109 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.38400821 |
| 110 | Insulin resistance_Homo sapiens_hsa04931 | 0.38359903 |
| 111 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.37748058 |
| 112 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.37525678 |
| 113 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.37307150 |
| 114 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.36793148 |
| 115 | ABC transporters_Homo sapiens_hsa02010 | 0.34930556 |
| 116 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34841931 |
| 117 | Peroxisome_Homo sapiens_hsa04146 | 0.34300706 |
| 118 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.33178526 |
| 119 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.33049860 |
| 120 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.30855474 |
| 121 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.30728381 |
| 122 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.29282619 |
| 123 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 0.29115368 |
| 124 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.28323326 |
| 125 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.27955029 |
| 126 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.27930743 |
| 127 | Colorectal cancer_Homo sapiens_hsa05210 | 0.27799218 |
| 128 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27741310 |
| 129 | Prostate cancer_Homo sapiens_hsa05215 | 0.27562647 |
| 130 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.27205265 |
| 131 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.26755733 |
| 132 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.24764245 |
| 133 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.24379178 |

